241 related articles for article (PubMed ID: 399843)
1. Immunological markers in non-Hodgkin's lymphomas.
Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
[TBL] [Abstract][Full Text] [Related]
2. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
Pinkus GS; Said JW
Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
[TBL] [Abstract][Full Text] [Related]
4. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
Davey FR; Goldberg J; Stockman J; Gottlieb AJ
Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
[TBL] [Abstract][Full Text] [Related]
5. Immunologic surface markers in non-Hodgkin's lymphomas.
Cossman J; Schnitzer B; Deegan MJ
Am J Pathol; 1977 Apr; 87(1):19-32. PubMed ID: 322504
[TBL] [Abstract][Full Text] [Related]
6. Cytomorphologic characteristics of non-Hodgkin's lymphoma.
Bizjak-Schwarzbartl M
Acta Cytol; 1988; 32(2):216-20. PubMed ID: 2450436
[TBL] [Abstract][Full Text] [Related]
7. Immunologic classification of non-Hodgkin's lymphomas: current status.
Seligmann M; Brouet JC; Preud'homme JL
Cancer Treat Rep; 1977 Sep; 61(6):1179-83. PubMed ID: 332351
[No Abstract] [Full Text] [Related]
8. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
[TBL] [Abstract][Full Text] [Related]
9. Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulosarcomas (non-Hodgkin's lymphomas).
Mathé G; Belpomme D; Dantchev D; Pouillart P
Biomedicine; 1975 May; 22(3):177-85. PubMed ID: 809067
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic expression of non-Hodgkin's lymphomas in China.
Xu LZ; Tu LY; Liu YF; Hsu SM; Qiu BS; Li ZX
J Natl Cancer Inst; 1984 Sep; 73(3):635-8. PubMed ID: 6236322
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin's lymphomas of the lung. A study of 19 cases emphasizing the utility of frozen section immunologic studies in differential diagnosis.
Weiss LM; Yousem SA; Warnke RA
Am J Surg Pathol; 1985 Jul; 9(7):480-90. PubMed ID: 3879107
[TBL] [Abstract][Full Text] [Related]
12. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
13. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification.
Kalyan K; Basu D; Soundararaghavan J
Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715
[TBL] [Abstract][Full Text] [Related]
15. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of immunophenotype in aggressive non-Hodgkin's lymphoma.
Tsartsidze E; Betaneli M
Georgian Med News; 2006 May; (134):107-9. PubMed ID: 16783081
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
18. New approaches to the classification of the lymphomata.
Lukes RJ; Collins RD
Br J Cancer Suppl; 1975 Mar; 2():1-28. PubMed ID: 1101914
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma.
Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T
Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995
[TBL] [Abstract][Full Text] [Related]
20. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
